Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Kristina Narfstrom, DVM, PhD, DipECVO Professor of Veterinary Ophthalmology III. RETINAL DEGENERATIVE DISEASE DOG INHERITED RETINAL AND TAPETAL DYSTROPHIES All cellular layers of the retina are potentially susceptible to the development of hereditary abnormalities. However, most of these relate to the parts that are physiologically most complex, the layers of the photoreceptors and the retinal pigment epithelium. In the canine there is a broad range and diversity of inherited retinal diseases that affect these structures. An important reason for this is certainly the establishment of different dog breeds and the custom to inbreed dogs that has favored the emergence and expression of recessive genes that cause a wide spectrum of retinal and tapetal disorders. Similar diseases also affect man and the canine diseases therefore seem to offer a convenient basis for comparison. The paucity of knowledge concerning the underlying biochemical, physiological and morphological disease mechanisms of man renders dogs with similar diseases especially important as animal models. Thus, the rat, mouse, chicken, cat, and also the dog, are frequently used for comparative studies of human tapeto-retinal dystrophies. Classification of the canine retinal dystrophies. Canine retina dystrophies can affect the photoreceptors and/or the retinal pigment epithelium primarily. Since the first well-documented report of an inherited retinal degeneration in the Gordon Setter was reported in Sweden by Magnusson, 1911, a large number of dog breeds have been found to be affected by hereditary retinal dystrophies. To these conditions the general term “progressive retinal atrophy” (PRA) has been applied. Clinicians have, throughout the years, divided the disease complex PRA into two types, depending on the ophthalmoscopic appearance of fundus lesions. In generalized PRA there is generalized hyperreflectivity of the retina at the end stage of disease, indicating a generalized atrophy of the retinal structures and clinical blindness. In central PRA (CPRA) there are multifocal accumulations of pigment within the retina and encircling these changes there are areas of hyperreflectivity at the end stage. The latter disorder is a primary defect in the retinal pigment epithelium, a disorder that not always leads to blindness. Thus, the two disease entities represent completely different disorders. During the last few decades PRA has been further subdivided into more specific diseases at the cellular level, for many of the diseases gene symbols are used. The term CPRA is currently being replaced by the term retinal pigment epitelial dystrophy (RPED), which more specifically relates to the disease entity. The classification of hereditary retinal degenerations is an issue of different opinions and discussions. Since the diseases are so diverse as to structures involved and pathogenesis, a strict classification is not feasable and perhaps not scientifically correct. It is, however, possible to subdivide PRA grossly into developmental and degenerative diseases. The developmental class represents a large aggregate of genetically distinct disorders which are expressed cytologically in the postnatal period, at the time that the visual cells are beginning to differentiate. These developmental disorders represent a dysplasia of the rod and/or cone photoreceptors and each has its own unique disease course and phenotype, as assessed by functional and morphological criteria. Typical for the dysplasias is that they, before the retina is adult-like at about 6 weeks of age in the dog, show rather severe structural alterations of the photoreceptor cells, while the rate of progression and, in most cases, loss of cones in the disease process is varied. In contrast, the degenerative type of diseases represent defects in which photoreceptor cells degenerate after having differentiated normally. In the latter group, disease occurs more slowly and is modified by temporal and topographical factors. Different alleles have been identified at the same gene locus (prcd) and these segregate to regulate the rate of photoreceptor degeneration. Within the retinal dysplasia and degeneration groups, the diseases are further subdivided according to the type of cell that is primarily affected, for example rodcone dysplasia of Irish Setters or cone degeneration of Alaskan Malamutes. However, for several diseases not sufficient data on morphology or electrophysiology is available and the expression PRA is then appropriate to use in relation to the lay public. The generic term retinal dystrophy, which implies heredity and lack of normal structure, may also be applied to the hereditary retinal diseases and is particularly useful in describing new disease conditions until a specific name is substantiated with further research. Clinical signs of PRA The clinical manifestations of PRA are often remarkably similar, no matter what type of disorder at the cellular level. The non-specific features associated with primary photoreceptor degenerations leading to retinal atrophy will be described in short. Particular features associated with specific genetic disorders will be further described later in the text. PRA is always bilateral and always leads to blindness. It should be emphasized that familiarity with the environment can greatly conceal severe visual deficits and it is not unusual to obtain animals for diagnosis late in the disease process, since owners have noticed visual problems after having moved or refurnished their homes. Almost always the earliest clinical sign is impaired vision in dim light and darkness (nyctalopia or night blindness). The reduced visual capacity in darkness may often be observed by visual testing. This is done by testing the menace reaction or by using falling cotton balls in front of the dog in a dimly lit room. Ophthalmoscopically, some change in tapetal reflectivity or hyporeflectivity is often seen, such as a grayish discoloration mainly in the peripheral tapetal fundus. A slight vascular attenuation and beading of retinal vessels in the midperipheral and peripheral parts of the tapetal fundus may be observed at this early stage as well. With progression of disease the color changes in the tapetal fundus become more marked and generalized as well as the vascular attenuation. In moderately advanced and advanced stages of disease there is an increase in reflectivity, hyperreflectivity of the tapetal fundus, usually most marked in the midperipheral tapetal fundus. The hyperreflectivity progresses to involve all parts of the tapetal fundus. There is also depigmentation of the non-tapetal fundus at moderately advanced and advanced stages of the disease. Vascular attentuation becomes marked and, especially at the advanced stage, only contours of vessels (ghost vessels) are observed centrally in the fundus. The area that often appears most spared late in the disease is the central part, as a discolored streak somewhat dorsal of and on both sides of the optic disc. In the non-tapetal fundus funduscopic changes are usually not seen until at the moderately advanced or advanced stages. Then there is often a patchy distribution of pigment in the non-tapetal fundus with areas in between that are depigmented. These changes are often described as “pavementing” of the non-tapetal fundus. The optic disc often becomes pallid with progression of disease and indistinct borders are often observed. The reasons for this is the loss of retinal circulation that occur in the retinal degenerative process, and the specific degeneration of neural tissue and comparably an increase in myelination at the level of the optic disc. The pupillary light reflexes become progressively more sluggish in the disease and the resting pupillary opening is often wider in affected animals than in the normal population. Often the pupillary light reflexes are not lost entirely in PRA, a feature that is useful in the differential diagnosis of blindness. Secondary cataract is almost always present in dogs in advanced stages of disease. The initial changes tend to occur in the posterior cortex and include vacuolation and opacification. Often irregular radiations are seen from the posterior pole of the lens that extend to involve the equatorial cortex and later progress to involve the entire lens. Mature cataracts, especially in certain breeds, make electroretinography of utmost importance, in order to rule out retinal degeneration before performing cataract surgery. Late-onset retinal degenerations Progressive rod-cone degeneration (prcd) of the Poodle Hereditary degenerations of the dog retina have since long been termed “progressive retinal atrophy” (PRA). During the past years, however, this disease complex in various breeds has been further subdivided and specified. Thus, the term “progressive rod-cone degeneration” (prcd) today refers not only to classical PRA but also to a specific photoreceptor disorder with several characteristics: bilateral late onset disease of the rods primarily, then of cones, typical ERG findings in affected animals, and a typical spatial distribution of disease seen morphologically. Genetic homology has been found for prcd so far in a total of 19 breeds, among which are: Toy and Miniature Poodle, American and English Cocker Spaniel, Labrador Retriever, Chesapeake Bay Retriever, and the Portuguese Water Dog. The list of prcd breeds gets longer for each year! There is today a mutation detection test available for the defect. Structural and functional abnormalities in progressive rod-cone degeneration (prcd) of the Toy and Miniature Poodle do not become evident until after the visual cells have developed normally. The disorder is inherited as an autosomal recessive gene. Of the degenerative group of hereditary retinal diseases recognized in dogs, mutations at the prcd gene locus account for all of the autosomal diseases recognized to date (Aguirre Exp Eye Res 46:663, 1988). The prcd gene and the different mutations responsible for the defined allelic variants that occur in dog breeds (see below) are not yet identified. So far the peripherin/rds, opsin and PDEbeta genes have been excluded as causative (Acland Invest Ophthalmol Vis Sci 36:S891, 1995 and Wang Invest Ophthalmol Vis Sci 36:S772, 1995). The frequency of prcd in the Poodle breed has been high over the years, and appears to be still rather high; the prevalence being 8% of the Miniature Poodles examined in Sweden during a 20-year period (Statistics from the Swedish Kennel Club, Jan 1,1996). Night blindness is the first behavioral sign observed in affected dogs, usually at the age of 3-5 years, but there is considerable variation in debut. Imparied vision does usually not become obvious to the owner earlier unless the dog is placed in an altered environment and furniture or other obstacles in the home are rearranged. Affected dogs may be apprehensive of the dark and experience particular difficulty in negotiating stairs. Night blindness is followed by reduced vision also in daylight and finally complete blindness, at a variable age, usually between 5-7 years. The rate of progression is believed to be faster in dogs that become affected at a young age compared to those that develop the disease later in life. The development of secondary cataract may exacerbate vision loss and therefore influence the age at which the condition first becomes apparent to the owner. It is not unusual that owners have only noticed the marble-like, white, opacified lenses and want a cataract extraction to be done. This is where ERG plays an important part, in order to rule out retinal degeneration, before even reflecting on performing surgery. Ophthalmoscopic fundus changes are usually prevalent by the time the owners have noticed visual problems. Often, affected dogs are found during routine ophthalmoscopic examination. Usually a change in tapetal coloration is seen, into grayish discolorations, most prevalent in the midperipheral and peripheral tapetal fundus, near the border of the non-tapetal fundus. This is followed by a progressive attenuation of the retinal vessels commencing with the small arterioles. Loss of pigment is usually not seen until the disease has progressed to a more advanced stage. A change in tapetal reflectivity and hyperreflectivity is then observed, mainly in the midperipheral and peripheral tapetal fundus. At the advanced stage of disease radial striae are seen in many cases, in the midperipheral and peripheral fundus, caused by the choroidal vasculature, underneath the atrophic neural retina. The vasculature is severely attenuated at this advanced stage. Eventually the retinal vessels virtually disappear and the optic nerve head atrophies, becoming pallid and irregular in outline, and later reduced in size. ERG studies in affected Poodles have shown a normal maturation of retinal function. At 28 weeks of age, however, affected dogs had ERG responses that failed to increase in amplitude with dark adaptation, and the dark-adapted responses were lower in amplitude than normal. With progression of disease the response amplitudes decreased. By 18 months only small b-wave amplitudes were recorded in response to red and white stimuli. Another group of researchers have failed to detect abnomalities of rod and cone responses until 10 months of age. The variation in results could be due to differences in ERG procedures or in the phenotype of dogs. There is usually a rather great variation as to disease debut and progression. However, in practical terms, ERGs from dogs less than 10 months are unlikely to be meaningful in the early detection of PRA in the breed. Light microscopically the photoreceptors of affected dogs develop normally, but at 14.5 weeks there was disorganization of some outer segment lamellae, observed by ultrastructure as well as vesicular profiles in the sclerad half of the outer segment layer. Cone photoreceptors were morphologically normal at this early age. At 30 weeks, there were distinct abnormalities in rod outer segments, evident also by light microscopy. In young prcd affected dogs there is a central to peripheral gradation of disease severity. There is a highly characteristic sequence of disease in prcd that has been staged as to structure into 3 major phases: 1) early disease (stage 1-1), 2) degeneration (stages 2-4), and 3) atrophy (stages 5-8). Starting at the age of 12-14 weeks, all photoreceptors cells begin to develop the stage-specific pathology characteristic of the disease, but the rate of progression is dependent on topographic factors. Pathology is always more severe in the inferior quadrants, while the visual cells in the superior and temporal retinal quadrants are spared until later in the disease process. So far, no specific properties have been identified in the inferior retinal quadrant that selectively predisposes this area to earlier and more severe disease. Moreover, the rate of progression of disease is not influenced by the presence or density of pigmentation of the retinal pigment epithelium. Throughout the three phases, the pigment epithelium remains normal in affected animals. Only in very advanced disease the pigment epithelium will show non-specific atrophic changes and sometimes also migratory responses. Cone pathology is not obvious until later, after rods have begun to degenerate, e.g., stage 2 and later stages. Because of structural differences between the disc membranes of rod and cone outer segments, renewal by membrane addition cannot be followed in cones. The label in this type of photoreceptor diffuses laterally and longitudinally throughout the entire cone disc membrane domain. Because of this, the early phases of renewal in prcd using retinal explants were performed to evaluate the transfer of newly synthesized protein label from the photoreceptor inner to the outer segments. In this in vitro study, the renewal defect was observed, as previously, in rods but not in cones. Thus, the disease in cones certainly appears to be secondary to a primary defect in rod photoreceptors. Using the techniques of lectin immunocytochemistry, the molecular components of the insoluble interphotoreceptor matrix have been studied in order to determine if abnormalities are present in prod-affected retinas. With the exception of the late atrophic stages of the disease, the lectin specificity remains normal, indicating that the photoreceptor specific insoluble interphotoreceptor matrix constituents are not primarily involved in prcd. Autoradiographic studies of affected retinas following intravitreal injection of tritiated leucine or tritiated fucose have shown a reduced rate of rod outer segment renewal, a finding shown to precede the appearance of structural changes. This hallmark abnormality identified in prcd rods is a uniform decrease in renewal, initially of 30-35%, that is associated with disease stage 1. Thereafter, renewal decreases further and rod disease and degeneration progresses. The transition from stage 1 to stage 2 marks the end of renewal by membrane addition and only low levels of diffuse label are present in the rod outer segments in stage 2 and later. Associated with stage 1 and 2 transition is a decrease in the expression of opsin mRNA transcripts and immunoreactivity. It is interesting to find that all rods demonstrate the same changes in opsin mRNA and immunoreactivity as well as the renewal deficits regardless of their topographic position. Several other photoreceptor-specific proteins have been studied in prcd by using immunocytochemical techniques. The change in immunoreactivity for each one has been found to be unique. The most stably expressed protein appears to be IRBP, which demonstrated sustained labeling of the interphotoreceptor matrix even after most of the photoreceptors had been lost. In the search for systemic markers in human retinitis pigmentosa and animal models of the disease, several research groups have investigated the level of plasma lipids in affected individuals. In Miniature Poodles, significant lower levels of plasma docosahexaenoic acid (22:6n-3) have been found when affected dogs were compared to normals. The effects of supplemetation of 22:6n-3 on polyunsaturated fatty acid metabolism were furthermore determined in normal and affected dogs. The results showed that there certainly is a defect in 22:6n-3 metabolism in prcd-affected animals. It is not clear yet if there is any correlation between the reduced renewal rate of photoreceptor outer segments, the lower 22:6n-3 levels and retinal degeneration in prcd-affected dogs, however. Progressive rod-cone degeneration (prcd) in the English Cocker Spaniel Crossbreeding experiments with prcd-affected Miniature Poodles and retinal degenerate English and American Cocker Spaniels have shown that the gene mutation in each breed is at the same (prcd) locus. In pure-bred English Cocker Spaniels, however, the disease differs phenotypically in the rate of progression of disease and in the topographical distribution of disease in the retina. Clinically, prcd in the Enligh Cocker Spaniel is phenotypically expressed late in life with funduscopic alterations indicative of retinal degeneration usually not prevalent until between the age of 4-8 years. Moreover, the fundus appearance in affected dogs may be quite variable. In some cases there are changes as those described earlier for the disease, although in others, the retinal alterations vary greatly in severity in different areas of the fundus. Thus, hyperreflective streaks can be seen centrally on either side of the optic disc, while other areas are brownish-gray in appearance and other quite normal appearing. Secondary cataracts are usually found early in the disease process. Diagnosis by ERG is also not possible until comparably late, in some cases at the age of 1 year, while in others not until after the age of 1.5 years. A few cases may have ERG-responses that are indistinguishable from normal dogs up to 2-2.5 years. Early ERG changes consisted of mild decreases in the b-wave amplitude to scotopically balanced red and blue light stimuli and white light stimuli, with normal b-wave implicit times. Flickering light stimuli at different frequencies readily differentiated rod and cone responses and showed unequal functional deficits. Rod components were affected earlier and became non-recordable earlier than cone components. Isolated rod signals could not be elicited at a time when cone signals were still distinct. It was shown that prcd affected Miniature Poodle lost b-wave function at approximately twice the rate as affected English Cocker Spaniels. Morphological findings corroborated the clinical findings, especially in cases of advanced disease. In early disease, changes were limited to rod outer segments and mainly seen as disorganization of outer segment lamellae. Later, degenerative changes were seen in outer and inner segments as well as in photoreceptor nuclei of rods. Phagocytic cells were often present in the subretinal space at this degenerative stage. In late atrophy the inner retinal layers were affected as well. By light microscopy, the changes appeared similar to those described for prcd of Miniature Poodles. At the ultrastructural level, however, the pathology was somewhat different and, importantly, the temporal and spatial distribution of visual cell lesions varied between the two breeds. In the English Cocker Spaniel, vesicular profiles were absent or present in only small numbers in early stage of disease. Also, there was a varying distribution of disease that was readily observed in spatial maps constructed. Disease was more severe in inferior than superior, temporal or nasal meridians, although there was a great variation as to severity of degenerative changes within meridians. Moreover, not all locations degenerated at the same rate. Older animals showed a “mosaic” of different disease stages across a meridian. The most significant difference in English Cocker Spaniel prcd compared to Miniature Poodle prcd was in the rate of degenerative changes and confirmed the results of the ERG observations. Progressive rod-cone degeneration (prcd) in the American Cocker Spaniel Test-breeding studies have shown that prcd of American Cocker Spaniels is genetically similar to prcd of Miniature Poodles and English Cooker Spaniels. Again, there are differences in retinal degeneration phenoptype between the breeds, which could represent different mutations at the prcd locus or that the same mutation is present although the disease modified or regulated by the genetic background of the animal. Clinically-affected dogs become night blind at the age of 3-5 years. There is also a successive reduction of visual capacity in daylight and within 1-2 years they are blind. Secondary cataracts are prevalent, often from the moderately advanced stage. Ophthalmoscopically, early changes may be seen from the age of 2.5-3 years or later. Most often there is a generalized change in tapetal reflectivity with a slight vascular attenuation. With time, the tapetal fundus becomes hyperreflective, first in the midperipheral and peripheral tapetal area. The central parts of the fundus are usually spared late in the disease process as seen by ophthalmoscopy. There are some difficulties in the diagnosis of fundus changes in the American Cocker Spaniel that need to be discussed. It is not unusual that individual animals have a thin and uneven peripheral tapetal border. In this area there is often a gray to brownish sheen that may look like an early stage of prcd. Also some dogs may have focal, circular but most often curvilinear, folds in the peripheal tapetal fundus. With time these lesions may become pigmented and even have hyperreflective parts, which is indicative of scar formation. Because of these aberrations it is not unusal to have to perform ERG in order to rule out prcd in the American Cocker Spaniel. Just as in the Miniature Poodle, an early diagnosis of prcd is possible in the American Cooker Spaniel at the age of 9-10 months. Also, morphologic studies have shown alterations that are comparable to Miniature Poodle prcd. Progressive rod-cone degeneration (prcd) in the Labrador Retriever Progressive rod-cone degeneration (prcd) has been a significant problem in the Labrador Retriever in Scandinavia for more than 20 years, although this finding did not attract much attention until rather recently. Studies have shown the disease to be genetically similar to prcd in the Miniature Poodle, English and American Cocker Spaniel and the Portugese Water Dog, which indicates that the diseases in each breed are at the same locus on the chromosome. Clinically-affected animals become night blind rather late, usually between the age of 4-6 years. There is a slow progression of the visual problems, and affected dogs have severe visual impairment at the age of 6-8 years. There are, however, considerable variations to this finding. In solitary cases, visual impairment has been observed as early as at the age of 2.5 years and blindness has prevailed only 2 years later. Ophthalmoscopically, changes are usually seen in the midperipheral and peripheral fundus, as a change in tapetal reflectivity. Often a horizontal streak on both sides of the optic disc in the tapetal area is seen with a marked grayishbrown discoloration. The changes in the midperipheral area progress to complete hyperreflectivity of the tapetal fundus, and severe vascular attenuation is the end stage. In many cases, the central fundus is somewhat spared late in the disease, with the grayish streak still observed on either side of the optic disc. ERG studies have shown a successive reduction of scotopic b-wave amplitudes. Rod function is severely reduced while cone function is spared until late in the disease. Definite diagnosis by ERG is possible by 15 months using an ERG under stable recording conditions. However, a recent study by Kommonen showed that by using a sensitive DC-ERG system, significant differences were found between affected and normal dogs as well as between dogs heterozygous for the defect and normal dogs by the age of 3-4 months. Analysis of retinal morphology in the disease has shown changes already at a comparably early age. As early as the age of 1 month, distinct alterations were found in the rod outer segments of the central tapetal fundus, whereas the midperipheral and peripheral areas were normal until at least the age of 5 months. Light- and electron microscopy have shown degenerative changes in photoreceptors at the age of 5 months in affected dogs. After this age there is a slow progression of disease, as described for prcd in the Miniature Poodle. Progressive rod-cone degeneration (prcd) in the Portugese water dog This breed of dog has recently been described as having prcd. The diseases in these prcd breeds are genetically similar and inherited as a simple autosomal recessive trait. The ophthalmoscopic diagnosis in the Portugese water dog is possible to make between the age of 3-6 years and ERG is diagnostic at 1.5 years. Hereditary retinal degeneration (XLPRA) in the Siberian Husky and in the Samoyed. Hereditary retinal degeneration in the Siberian Husky and in the Samoyed has been described in clinical cases as PRA. There seemed to be an excess of affected male dogs with the disorder and further studies including test-breeding schemes showed that there is an x-linked transmission for the disease. In fact, these are the first xlinked retinal degenerations described in an animal. Clinical signs of the disease are usually observed at the age of 2-4 years, including initial night blindness and early ophthalmoscopic sign of retinal degenerative disease. ERG findings in affected dogs include diminished rod-mediated function as described for progressive rod-cone degeneration of other breeds. Morphologic evidence for XLPRA are also comparable with that of the previously described affected dog breeds, although details at the ultrastructural level have so far not been published. Progressive retinal atrophy in the Tibetan Terrier PRA in the Tibetan Terrier was first described in Sweden and later in England. An autosomal recessive inheritance for the defect was established through a testbreeding scheme and the disease was further investigated using electrophysiologic and morphologic techniques. Recently, molecular genetic studies examining the opsin gene for polymorphism have been performed in the Tibetan Terrier as well as in the Miniature Schnauzer, the Irish Setter, the Miniature Poodle, the Labrador Retriever, and the English Cocker Spaniel dog breeds. Two polymorphisms were found. One segregating within the Tibetan Terrier population, but not in the other breeds, was a synonymous transition at nuoleotide position 780 in exon 3. Inheritance of this polymorphism suggests that opsin is unlikely to contain mutations causative of PRA in this breed. The clinical signs of disease in affected Tibetan Terriers are rather early, compared to prcd affected dogs. Night blindness is often found well before the age of 1 year. The disease has a fast progression and blindness is not unusual before the age of 2 years. At this early age, the pupillary light reflexes are slow and incomplete. Bilateral cortical and then complete cataracts are often seen to develop after the age of 4 years. Typical funduscopic signs of disease are grayish tapetal discoloration in the midperipheral and peripheral fundus and very soon also a slight vascular attenuation. The discoloration changes toward hyperreflectivity as the degenerative disease progresses further, especially in the peripheral tapetal fundus. These alterations spread centrally to involve all tapetal areas and especially prominent around the optic disc, which becomes pale and devoid of its normal vasculature. The end stage is a generalized atrophy also observed in the non-tapetal fundus, where depigmented areas surround hyperpigmented spots. ERG findings include a reduction of the scotopic b-wave at about the age of 10 months but normal timing characteristics at this age and normal sensitivity of the b-wave responses. After the age of 30 months the ERG is non-recordable. Light-microscopy did not show any major aberrations at 10 weeks of age in affected dogs. However, at 8 months the neural retina had thinned considerably and at 24 months there was a generalized atrophy of the retina and the outer nuclear layer was reduced to only 3-4 rows of photoreceptor nuclei. By ultrastructure, distinct alterations were observed in rod and cone outer segments as early as 10 weeks of age in affected dogs. Interspersed between normal rod and cone outer segments were others (both rod and cone) outer segments that were severely disorganized and disoriented. Numerous vesicular profiles were seen in the interphotoreceptor space at this early age. Also, the changes were seen in all sections from different areas of the retina. Progressive retinal atrophy in the Tibetan Spaniel Cases of PRA have been found during the past years in several countries, including England, Sweden, Norway and the U.S. The clinical findings in the disease were recently described. Ophthalmoscopic signs of disease have been recorded from the age of 3-5 years. Affected dogs lose vision thereafter rather quickly and are severely visually impaired already after another year. Funduscopic changes are the classical ones for the late onset type of PRA: hyperreflectivity of the peripheral tapetal fundus and severe attenuation of retinal vessels. The retinal atrophic changes spread inwards towards the optic disc. Secondary cataract is seen in older affected dogs but does not seem to be an early finding. Due to variation in tapetal distribution and size, the fundus of the Tibetan Spaniel is highly variable, causing difficulties in obtaining an early ophthalmoscopic diagnosis. ERG is an invaluable aid under these circumstances. Electrophysiologioal and histopathological data are not yet available. Progressive retinal atrophy in the Miniature Longhaired Dachshund A form of progressive retinal atrophy, unlike other previously recorded canine retinal degenerations, has been reported in the Miniature Longhaired Dachshund. Segregation patterns in litters from matings involving affected individuals were consistent with simple autosomal recessive inheritance. The earliest ophthalmoscopic signs appearing at about the age of 6 months and coinciding in some cases with the onset of night blindness. Early funduscopic changes consisted of a granular appearance of the tapetal fundus followed by a generalized tapetal hyperreflectivity and vascular attenuation. With progression there was an irregular loss of pigment in the non-tapetal fundus and optic disc atrophy. At the onset of ophthalmoscopic sign, the pupils appeared partially dilated and the pupillary light reflexes slugish and incomplete. There was a marked variation in the age of onset and also in progression of disease, also in a single litter. ERG showed a normal waveform at 10 weeks, while at 9 months the ERG amplitudes were markedly reduced and even non-recordable in some dogs. Results of recent ERG studies have, however, shown that the defect in this breed is a cone rod dystrophy. The genetic mutation has been found and a mutation detection test has recently become available. Morphologically, no definite changes were found by light-microscopy at the age of 6 weeks. However, by 10.5 weeks, there was reduction in thickness of the outer nuclear layer, indicating a photoreceptor loss. Rod outer and inner segment were irregular in form and there was disorganization of outer segment lamellae. With progression of disease there was advanced degeneration of photoreceptor outer segments and atrophy of inner segments. Not only was the photoreceptor cell layer diminished but also the outer plexiform layer. It appeared that the changes in the central retina were less severe than those of the peripheral retina. In Norway, cases of a retinal dystrophy in the Wiredhaired Dachshund have also been found during recent years. The disease appears to be a cone rod dystrophy with early functional defects such as day blindness. Initial, funduscopic alterations are found between the age of 3-5 years and there is a slow progression of the disease. A generalized change in tapetal reflectivity is seen with discoloration and severe mottling of the retinal pigment epithelium is found. ERGs are most often diagnostic for the defect and show low amplitude cone responses initially. A generalized retinal atrophy is found within 2-3 years after initial clinical findings. Progressive retinal atrophy in the Akita Progressive retinal atrophy in the Akita dog has been described as a variable disease as to first appearance and type of initial clinical symptoms. In this recessively inherited disease night blindess occurs between 1 and 3 years of age, with complete blindness developing between 3 and 5 years of age. Ophthalmoscopically, two patterns of initial funduscopic changes have been described: the most common involves a hyperreflective horizontal band in the central tapetal fundus, first seen in the area centralis region and then extending horizontally on either side of the optic disc; the other pattern is characterized by retinal alterations, indicative of retinal thinning, in the peripheral tapetal fundus. With progression of both patterns there is a generalized hyperreflectivity of the entire tapetal fundus, vascular attenuation and atrophy of the optic nerve head. Early ERG findings include significant reductions of the scotopic b-wave amplitudes in dogs less than a year. Dark adaptation curves are abnormal but there appears to be both rod and cone dysfunction. Since there appears to be a great variation as to electrophysiologic changes in the disease, a definite diagnosis by ERG is not obtained until the age of 1.5 to 2 years. Progressive retinal atrophy in the Papillon dog Progressive retinal atrophy has recently been described in the Papillon breed of dog in Sweden. In a study of 707 dogs, 5% were affected with a retinal degenerative disease. The disease appears to be inherited by an autosomal recessive gene, and has a late onset and slow progression of clinical symtoms. Clinically-affected dogs very seldom show evidence of visual impairment, even at a late stage of disease. Night blindness is, however, a symptom that may be found in some middle-aged dogs upon visual testing in dim light and in darkness. Blindness is prevalent at a late stage, usually not until after the age of 7-8 years. Ophthalmoscopic findings as well as progression of disease is similar to what has been described for prcd in the Miniature Poodle. Secondary cataracts have, so far, NOT been a prevalent finding in affected dogs, as is found in most other dog breeds affected with PRA. There is a great variability in extent and coloration of the visible tapetum in the Papillon breed. Some dogs lack visible tapetal cells and some dogs have subalbinotic eyes. These variables often render diagnosis difficult. ERG is extremely useful in such eyes but also for the early diagnosis of disease in dogs with the more common fundus appearance. Groups of Papillons have been evaluated using ERG. Full-field Ganzfeld ERG was used to test outer retinal function in 45 young normal and affected Papillons. Eleven specific responses were recorded, plotted into graphs and evaluated using age-matched groups of dogs. A severely decreased retinal function in 8 Papillons, the youngest at the age of 1.2 years, was found. Amplitudes of responses mainly originating from the rod system were severely reduced when the cone responses were only slightly reduced or even normal. The results showed that early diagnosis using ERG may be confidently performed by the age of 1.5 years in the Papillon breed of dog using techniques previously described. Morphologic studies corroborate the ERG findings. In a 7-year-old affected dog there was a generalized retinal degeneration of rods, primarily with less obvious degenerative changes in cones. There was a regional variation of severity of disease in that the inferior non-tapetal retina was more severely affected than the superior tapetal area. Dominant Progressive Retinal Atrophy In the Old English Mastiff and in Bullmastiff dogs, a specific retinal disease unlike those previously described has recently been found. When discovered the disease displayed an ambiguous mode of inheritance and therefore out-cross matings were performed in order to elucidate the specific mode of inheritance for the disorder. This was shown to follow a dominant pattern and the defect found is the first opsin mutation described for dogs. The gene defect is a T4R mutation, indicating a different cause of PRA than previously described in other breeds of dogs. Clinical examination in early disease by ophthalmoscopy and OCT showed a variably sized and located area of retinal thinning in the central fundus, clearly demarcated from surrounding clinically normal retina around the age of 6 months. Through clinical ERGs the disease was defined as a progressive retinal degeneration. ERG rod and cone-mediated responses were not significantly different between 2-month-old normal and affected dogs. By 12-18 months of age, however, affected dogs had severely reduced b-wave amplitudes. Defective dark (or bleaching) adaptation was also found in affected dogs. The non-uniform degeneration of photoreceptors detected was verified morphologically. The photoreceptors developed normally and were indistinguishable from normal at 9 weeks of age. In young affected adult dogs the regional distribution of disease was striking: normal appearing photoreceptors could be seen or showed different gradations of disease. In general, more severe disease was observed surrounding the optic nerve head but centered in the temporal tapetal region of the fundus. Beyond this there was an abrupt transition zone beyond which photoreceptors were structurally and quantitatively normal. Advanced retinal degeneration was observed at the age of 4.5-11 years. The disease is distinctly different from other canine retinal degenerations and the differences are exactly the similarities it shares with certain human rhodopsin mutations. The defect in dark adaptation and the focal initiation of photoreceptor degeneration characterize both this canine disease and human patients with Retinitis Pigmentosa (RP), due to class B1 rhodopsin mutations. An intriguing recent finding is that environmental light appears to contribute to the regional variation of early disease. It was found that modest light levels (such as used in routine clinical practice when performing retinal photography) dramatically accelerated the retinal degeneration. These findings do not immediately lead to modifications in clinical examination procedures. However, retinal photography should not be standard in human patients with rhodopsin mutations, retinal examinations should be of short duration and light exposure during intraocular surgery should be reduced. Similar recommendations also certainly appear valid for dog patients with the rhodopsin mutation. Progressive retinal atrophy in other dog breeds Progressive retinal atrophy has beed described in many other breeds of dog. They have, however, not been reported in detail in the scientific literature. Retinal pigment epithelial dvstrophy (RPED) The term central progressive retinal atrophy (CPRA) has been used over the years for a group of conditions having ophthalmoscopic changes that can be characterized by an accumulation of irregular foci or light brown pigment spots in the central tapetal fundus. With time, these foci increase in size and become distributed throughout the tapetal zone. At this stage there are also atrophic changes, e.g., hyperreflectivity around the pigment foci, which indicate atrophy of the overlying neural retina. The nontapetal fundus shows similar foci with hyperpigmentation and depigmented areas in between. The term CPRA was used in order to differentate the condition from generalized PRA. For many years it has been clear that CPRA affects the RPE primarily with secondary effects on the neural retina and that the condition is quite different from PRA, which affects the photoreptor layer primarily. It is the general opinion amongst veterinary ophthalmologists today that at least in those breeds, in which the defect has been established microscopically, the term “retinal pigment epithelial dystrophy” (RPED) is preferred to CPRA. RPED has been recognized in many breeds all over the world but perhaps most prevalent in England. In particular, cases have been recorded in Labrador and Golden Retrievers, Border Collies, Rough and Smooth Collies, Shetland Sheepdogs, the English Cocker Spaniel, English Springer Spaniel, Chesapeake Bay Retriever, among others. In the Briard, an unusual high frequency of the disorder was reported. In recent years, however, the condition is more rarely observed in the various breeds, including Briards, even in England. It has been suggested that RPED in the Labrador Retriever is inherited as a dominant trait with variable penetrans. The reduction in incidence, that has been accomplished in the Border Collie, through selective breeding is perhaps consistent with this view. A recessive mode of inheritance was thought likely for the Briard but has not been proven. Further studies are needed in order to elucidate whether there is a simple Mendelian inheritance for the defect or not. It is possible that a genetic predisposition in an individual breed can be modified by environmental factors. Important in this context is that lesions similar to RPED have been produced in dogs fed diets deficient of vitamin E, an antioxidant that retards the intracellular accumulation of lipofuscin pigment. Also, naturally-acquired retinopathy as a result of vitamin E-deficiency has been described in dogs. The similarities between CPRA/RPED and vitamin E deficiency may explain its unique geographic distribution. The ophthalmoscopic changes described above are often found before there are any signs of visual impairment in the dog. With progression of disease the pigmented lesions coalesce into widely spaced irregular patches with hyperreflective tapetal fundus in between. End stage atrophy includes a more generalized hyperreflectivity with sparse amounts of pigmented foci and/or stria, the latter findings not always obvious to the examiner. With these severely advanced changes, the ophthalmoscopic diagnosis is not always easy and similarities to generalized PRA may be found. Retinal changes are always bilateral in RPED, just as for PRA, and more or less symmetrical. ERG is not diagnostic in RPED, although there is a reduction in ERG amplitudes with progression of disease. The behavioural signs of RPED are typical. Visual impairment is usually not found until a moderately advanced stage of disease. Then, because of the relative sparing of the peripheral, compared to the central, retina, peripheral vision is retained until late in the disease. Vision tends to improve at low light levels. Also, vision may appear normal for moving and distant objects but impaired for stationary and objects near by. Not all affected dogs become blind. Secondary cataracts are most often seen at the advanced stage of RPED. In the Briard dog an extremely high frequency of the disease was found in a 5-year survey. Almost one-third of dogs examined (approximately 70% of the Briard population in England at the time) that were more than 18 months old were clinically affected. In this breed the typical pigmentary changes were first seen towards the periphery of the tapetal fundus temporal to the optic disc before spreading to involve the whole tapetal zone. There are, however, significant differences between the funduscopic alterations in the various breeds, which probably indicates a spectrum of disease entities at the retinal pigment epithelial level. In affected Briards, biochemical and morphological studies have been performed of retinal tissue and blood. These studies have shown that rod outer segment renewal is normal as well as acid phosphatase activity in the retinal pigment epithelium. Also some affected dogs have also been described to be hypercholesterolaemic and systemically deficient of vitamin E and taurine. Further investigations into the blood biochemistry of normal and affected Briards in the United Kingdom have shown that there is a hyperlipideaemia in Briards that is characterized by increased plasma cholesterol but normal triglyceride concentrations. There was no significant difference in plasma cholesterol concentrations between affected dogs and those that were ophthalmoscopically normal. The absence of obvious metabolic derangements associated with hypercholesterolaemia, suggest that Briards in the United Kingdom may have a primary abnormality in cholesterol metabolism. The possibility that abnormality in lipid metabolism might play a role in the development of RPED in Briards is being further investigated. Morphologic studies have shown that the earliest recognizable lesions in RPED are in the retinal pigment epithelium. The cells become hypertrophied and accumulate a light-brown granular material in the cytoplasm. Opposite the hypertrophied cells, the photoreceptor outer segments are shortened. With progression of disease, more cells become hypertrophied. At the end stage, hypertrophic pigment epithelial cells form multicellular nests. Focal degeneration is then seen of photoreceptors overlying the hypertrophied cells, followed by complete retinal degeneration with intraretinal migration of non-melanin containing cells. Diseased pigment epithelial cells contain autofluorescent lipopigment similar to ceroid or lipofuscin. Biochemical studies of retinas from affected dogs have shown that the pigment that accumulate in the disease varies with breed, and appears to be the result of peroxidation of rod outer segment lipids. Neuronal ceroid lipofuscinosis (NCL) Neuronal ceroid-lipofucscinosis (NCL), a group of inherited and progressive lipid storage diseases, is characterized by retinal degeneration and encephalopathy. They affects both human and several other animal species. The genetic defect has been elucidated for the infantile and juvenile forms in humans. A spectrum of apparent biochemical defects has been implicated in these disorders. The central nervous system appears to be the main focus of the pathogenetic defect and there are reasons to believe that this brain-specific abnormality is related to a biochemical event unique to nervous tissue. The disease has been described in several breeds of dog such as the English Setter, Dalmatian, Border Collie, Tibetan Terrier and others. The hereditary characteristic is mainly autsomal recessive in the breeds studied so far. A common clinical manifestation in both man and dogs is blindness that occurs together with a broad spectrum of neurologic abnormalities caused by the accumulation of autofluorescent lipopigments in neurons and other cells. With some exceptions the blindess is cortical in origin, since photoreceptor function and structure are generally preserved. There are some exceptions to this: in the Tibetan Terrier night blindness occurs in young animals and more severe neurologic abnormalities are not observed until later in life. Also, in the Polish Owczarek Nizinny (PON) dog visual dysfunction and tunduscopic alterations occur early in life, often between the age of 1-2 years. In most cases neurologic symptoms are found simultaneously or slightly thereafter. Ceroid-lipofuscinosis was also described in the Miniature Schnauzer. At the age of 3-4 years blindness developed over a 3-month period, accompanied by neurological signs. Pathology showed severe inner and outer retinal degeneration and extensive accumulation of fluorescent lipopigment in central nervous tissue and retina. In the English Setter, retinal function is initially normal at a time when neurologic abnormalities are present. In this breed clinical signs usually develop about at one year of age and include progressive blindness, ataxia, muscle weakness and dementia. The disease is ultimately fatal. The disease in Tibetan Terriers resembles that of the English Setter but the time course is longer. In the Tibetan terrier nyctalopia becomes evident as early as 2 months or age or earlier, but funduscopic changes, with similarities to PRA, do not appear until 3-4 years of age. The ocular changes appear to represent one part of a more generalized disease process. Specific functional and morphological characteristics have been described for some affected breeds. In the English Setter, ERG responses are normal in young dogs but become grossly abnormal with time. In advanced cases there c-wave of the ERG becomes non-recordable and there is a reduction of the standing potential of the eye. In the PON dog, the scotopic ERG responses were absent and the cone flicker responses reduced but recordable in a 2-year-old affected dog. The c-wave was replaced by a slow negative potential indicating a dysfunction of the retinal pigment epithelium. For the Tibetan Terrier, abnormal ERGs were recorded already at the age of 7 weeks. There was a complete lack of positivity and a large, monophasic negativity in the region of the normal b-wave of the ERG. Continued monitoring of ERGs with increasing age showed age-related changes indicative of a retinal degenerative process. Ultrastructurally intracellular inclusions with a granular appearance or containing membranous fingerprint-like material or curvilinear profiles, resembling ceroid, have been found in different retinal cells of PON dogs. Also in the English Setter and Tibetan Terrier breeds, inclusions accumulate in pigment epithelial and other retinal cells but also in CNS neurons. However, the association between neuronal lipopigment storage, cell dysfunction and cell death is presently not known. The genetic mutation has been found for some of the above described breeds and mutation detection tests are available for these. Mucopolysaccharide (MPS) storage diseases In both man and animals, mucopolysaccharide (MPS) storage diseases are caused by the inherited deficiency of lysosomal enzymes and represent generalized multisystemic abnormalities of which ocular lesions are but one component. The lysosomal enzymes participate in the degradation of glycosaminoglycans (GAGS). Morphologic studies show accumulation of intracellular inclusions in secondary lysosomes in the enzyme deficient retinal pigment epithelium. In dogs, MPS VII has been described. In the pigment epithelium single cytoplasmic inclusions are present initially during the early postnatal period. Their number and size increase during the period of photoreceptor differentiation. The pigment epithelial cells enlarge and the whole monolayer becomes hypertrophied. In spite of the pigment epithelial pathology, the neuroretinal structures and functions are preserved and there is no photoreceptor degeneration in the disorder. A late-onset lysosomal storage disease has been described in the Tibetan Terrier. The principal clinical manifestation includes visual loss, progressive cerebellar ataxia, and dementia. Morphologic studies indicate lysosomal storage of both lipid and carbohydrates. Hereditary tapetal degeneration An autosomal recessively inherited tapetal abnormality of laboratory Beagle dogs has been described. Affected dogs have a light, uniform choroidal pigmentation which precludes visualization of the choroidal vessels. Morphologically, there are normal numbers of tapetal cells at birth but, with time, there is a progressive degeneration of the tapetal cell layer. The retinal structure and function, however, remains normal. SPECIFIC RETINOPATHIES Uveodermatological / Voat-Koyanagi-Harada (VKH) syndrome The uveodermatologic or Vogt-Koyanagi-Harada (VKH) syndrome of man embraces a variety of clinical signs, including uveitis, choroiretinitis, depigmentation of skin (vitiligo), loss of hair pigment (poliosis), and various nervous signs. The disease has been reported in dogs as an immune-mediated syndrome which resembles VKH in man. Several cases have been reported in the Akita, although numerous other breeds have been affected as well. In dogs, cases are usually presented with a history of sudden blindness. Ocular examination may reveal anterior and/or posterior uveitis and serous retinal detachment. The uveitis is usually granulomatous, with cellular infiltrates of lymphocytes, plasma cells, epitheloid cells and macrophages containig ingested malanocytes. The cause of the disease is unknown, although the histopathology is consistent with antimelanocyte autoimmunity, and the breed incidence, such as in the Akita, suggests the involvement of genetic factors. Moreover, a relationship between circulating antiretinal antibodies and clinical signs has been found. This could indicate a breakdown of the blood-retina barrier and exposure to retina-specific antigens and a secondary production of the anti-retinal antibodies. Sudden acquired retinal degeneration (SARD) Sudden acquired retinal degeneration (SARD) is a retinal disorder of unknown etiology that causes a sudden and permanent blindness in adult dogs. There is no treatment for the disorder. Clinical signs are characterized by a sudden loss of vision, usually within days or 1-2 weeks, pupillary dilatation and unresponsive pupils, absence of ophthalmoscopic fundus abnormalities at the early stage, and an extinguished ERG. It appears that all breeds may be affected, even cross-breeds, and often in their middle-age. After several weeks to months, slight funduscopic alterations may be observed, indicative of a generalized retinal degenerative process. The end-stage is a generalized retinal atrophy that is indistinguishable from PRA. Affected dogs are usually healthy, but in some there is a history of weight gain, polyuria, polydipsia, and polyphagia. In some cases there have been elevations in serum alkaline phosphatase, serum amino transferase, serum cholesterol, or serum bilirubin. Frequently there are signs suggestive of hyperadrenocorticism. There have been speculations on involvement of faulty fat metabolism in the disorder. Also implications of an autoimmune mechanism stems from findings that dogs with SARDS had circulating antiretinal antibodies. Lately, attention has focused on a possible toxic etiology. Morphologically, abnormalities are restricted primarily to the photoreceptor cell layer. There is a rapid loss of photoreceptor outer segments, both rod and cone, followed by a degeneration of the other retinal layers. Different regions of the retina are equally affected, in contrast to many of the hereditary retinal degenerative diseases earlier described in dogs. Retinal toxicities Drug-induced retinotoxicity Compounds can cause retinal damage directly by damaging neuroretinal or retinal pigment epithelial cells or indirectly by inflammatory reactions that lead to focal or more generalized cell death. The assessment of retinal integrity is an essential component of ocular safety evaluation. Usually ophthalmoscopy and biomicroscopy of treated animals and histo-pathology of retinal tissues are used in routine toxicological studies. These methods are adequate to detect gross retinal degenerative changes. They fail, however, to detect minor pathology of the retina, such changes that involve subtle though generalized structural alterations without degeneration. Minor morphological changes may be elucidated using improved methods of tissue fixation and the use of both light- and electron microscopy. Functional evaluation can be done using electrophysiologic testing, such as ERG and/or VEP. In order to determine target-tissue specificity and examine mechanisms of compound associated retinal damage in vitro methods, such as tissue culturing can be used. Preliminary extended protocols for ocular toxicity testing have been proposed in some areas of toxicology. Drug-induced retinopathies are usually characterized by bilateral symmetry. There is usually a relationship between the duration of administration of the toxic compound, the dosage and the onset of clinical signs. Some well-known and representative drug-related retinotoxic compounds are provided below. -Ethambutol -Diphenylthiocarbazone (Dithizone) -Hydroxypyridinethione -Quinine and some of the cinchona derivates -Rafoxanide -Chloroquine is an antimalarian drug that has an affinity for melanin and ocular tissues containing melanin. In dogs, the earliest changes may be seen in the non- tapetal fundus as scattered gray-white specks. Histologically, membranous cytoplasmic bodies are seen in ganglion cells by ultrastructure. -Azalide is an antibiotic drug that can cause tapetal color changes if administrered in high doses (100-fold the recommended clinical dise). Ophthalmoscopically there was a dull white appearance of the tapetal fundus. Microscopic examination of ocular tissue showed tapetal cells that were swollen and vacuolated and retinal cells, primarily ganglion cells, that contained lysosomal lamellar bodies. No other effects were found in the eye or systemically. -Closantel is an antihelmintic used in domestic ruminants and intoxication has been described in a dog. Eye examination revealed bilateral mydriasis with absent pupillary reflexes. Funduscopically the optic discs were swollen and several small papillary and peripapillary hemorrhages were seen. The tapetal fundus was diffusely hyperreflective. Retinal vasculature appeared normal. With time there was progression of the lesions, which resulted in a generalized retinal and optic disc atrophy. Blindness was irreversible. Retinopathy induced by light and oxygen There is an association between high light intensity and retinotoxicity that is well established. Phototoxicity in the rat model has been extensively studied. Illumination of the canine fundus with the light from an indirect ophthalmoscope for 20 minutes may be sufficient to cause ophthalmoscopically visible changes. Prolonged exposure results in areas of increased granularity in the tapetal fundus, followed by retinal pigmentation and increased tapetal reflectivity. The non-tapetal fundus is, however, virtually non-affected, showing the protective effect of pigmentation. Histologic changes in minor retinopathies include vesiculation and shortening of photoreceptor outer segments but also vesiculation of the pigment epithelial cells. More advanced cases show photoreceptor degeneration and atrophy of the retinal pigment epithelium. It has been shown that exposure to high oxygen tensions produces selective damage to the visual cells in dogs. Oxygen administration has been strongly linked with human retinopathy of prematurity (ROP). Oxidative processes and the generation of free radicals have been suggested to be important in the development of the disease. Furthermore, light and oxygen can interact to produce oxygen-free radicals, a process known as photosensitization. Experimental studies in new-born Beagles showed clinical and histologic abnormalities in eyes exposed to light in the presence of rose bengal, a photosensitizing agent. A spectrum of retinal lesions were obtained including vitreous hemorrhage, fibrovascular and fibrocellular proliferation with traction on the retina, complete and partial retinal detachment and retinal dysplasia. The study showed that photosensitization can produce a spectrum of retinal pathology in dogs that resembles human ROP. Retinopathy induced by radiation Radiation-induced ocular injury secondary to treatment of nasal cancer occurs in humans and animals. In a clinical and histological study, immediate changes were found, such as blepharitis and keratoconjunctivitis. However, at 3-6 months post treatment (36-67.5 Gy in fractionated doses given in 4 weeks using a 6 MV linear accelerator) a degenerative angiopathy of retinal vessels appeared with multifocal retinal hemorrhage and mild diffuse retinal degeneration, first affecting the outer retinal layers but then progressing inwards. At 1-2 years post irradiation time, there was a moderate retinal degeneration with swelling and loss of ganglion cells and, subsequently, optic nerve axonal degeneration. Even tapetal and choroidal atrophy was observed. Thus, structures of the canine eye are sufficiently sensitive that even relatively low total doses of radiation cause significant long-term injury. Retinopathies of nutritional and general disease processes Vitamin deficiency Systemic vitamin A deficiency is characterized by night blindness in several species. In dogs, systemic diseases causing imparied fat absorbtion could cause vitamin A deficiency, although this clinical situation is extremely rare. Vitamin E is an antioxidant with an important function in maintaining the stability of cell membranes by preventing lipid peroxidation. A deficiency may result in pathologic changes in muscle, central nervous system, reproductive tract and retina Experimental studies by Riis, producing vitamin E deficiency, have been performed in dogs. At weaning, dogs were fed a diet deficient of Vitamin E. Ophthalmoscopic signs of disease developed early and were described as a mottled tapetal fundus appearance, particularly centrally, with numerous discrete yellowbrown foci. With time the central fundus became hyperreflective and there was an attenuation of retinal vessels. The ERG was non-recordable at the age of 4 months. Histologically, an accumulation of autofluorescent pigment within the retinal pigment epithelial cells was observed and, at later stages, in migrating cells in all retinal layers. Photoreceptor damage occurred in areas overlying affected regions of the pigment epithelium. After the age of 6 months, there was a complete atrophy of the photoreceptor layer. The obvious similarities between vitamin E deficiency and hereditary RPED suggest some common etiologic factor. CAT Lysosomal storage disease Inherited enzyme deficiencies or lysosomal storage diseases affect the retina as well as other body systems, such as the cornea as described earlier. The recessively inherited diseases include alpha-mannosidosis, manifested as a dull, gray, granular appearance of the area centralis region and GM1 gangliosidosis, associated with focal fundus lesions in the form of multiple small spots, which represent accumulation of glycolipid within the ganglion cells. Another lysosomal storage disease is mucopolysaccharidosis type VI, where there is a generalized retinal atrophy in most affected cats. This is also the case in gyrate atrophy, which represents a systemic ornithine deficiency and also results in blindness. Chediak-Higashi syndome As described above Chediak-Higashi syndome (CHS) is an autosomal recessive disease of cats and other species. Affected kittens have hypopigmentation not only of iris but also of retinal pigment epithelium (RPE) and changes in the tapetal cells. The tapetal cells do not seem to reach maturity, and ophthalmoscopically there is a lack of visible tapetum in affected cats. Ultrastructurally there is a loss of RPE cells and of tapetal cells with time. A membrane defect has been reported in CHS, involving an increase in unsaturated fatty acid content. This could lead to increased peroxidation of both phagosome derived and intracellular CHS-RPE membranes, making them resistant to lysosomal degradation. Progressive retinal atrophy (PRA) PRA was for many years reported in only a few breeds of cats and in few individuals in each report. Retinal degeneration with a suspected hereditary basis was described in Siamese Persian and in mixed-breed domestic cats in the U.S. In only one breed thus far is there hereditary PRA, proven through genetic studies, and that breed is the Abyssinian. It has also been shown that in the Abyssinian cat there are two specific types of retinal diseases and each one has a different mode of inheritance for the defect. Both are bilateral and more or less symmetrical in the two eyes and progressively lead to blindness. Progressive rod cone degeneration in the Abyssinian cat is a disease with an autosomal recessive inheritance. Classical early signs of PRA are found ophthalmoscopically in affected cats at the age of 1.5-2 years. There are tapetal color changes and slight changes in tapetal reflectivity and some vascular attenuation mainly in the midperipheral and peripheral tapetal fundus. With progression of disease, there are progressively more widespread changes indicating neuro-retinal thinning, showing as hyperreflectivity and severe vascular attenuation. The late stage is seen 3-4 years after the initial findings, when there is a complete bilateral retinal atrophy. Functionally, it has been shown by using electroretinography (ERG) and morphologically, by using light- and electron microscopy, that the retina develops mainly normally in affected cats up to the age when the retina is adult-like, at 5 months in cats. After that age there is a drop out primarily of rod photoreceptors and much later of cones. The neuro-retinal cell layers are successively lost, starting in the midperiphery and periphery. The central retina is spared until late in the disease process. The pathogenesis of this rod cone degenerative disease is so far not elucidated and further studies are in progress in order to find the gene defect. Early diagnosis of affected cats can be made by careful ERG studies at the age of 8 months, well before retinal changes are diagnosed by ophthalmoscopy. The frequency of the disease was calculated to be unusually high, up to 45% affected animals in Sweden, when first found. Through hard work mainly by the breeders in Sweden and with the help of an effective breeding program, the prevalence of the disease has been significantly reduced during recent years. The Abyssinian cat has become a valuable animal model for the study of hereditary retinal degenerative in man since the cat rod cone degeneration is similar to human Retinitis Pigmentosa (RP). Taurine deficiency retinopathy The amino acid taurine is found at high levels in shellfish, liver, and in meat; essential components in the daily diet of cats. With a lack thereof, a specific retinopathy develops. Ophthalmoscopically, a band retinopathy develops along the visual streak and an atrophic lesion is observed in the area centralis region. With time, the lesions progress and a generalized retinal degeneration is the end-stage of the retinopathy. Cone-mediated ERG is reduced early in the disease process and both cone and rod ERGs become non-recordable with time. If taurine is supplemented early in the disease, the retinopathy can be stopped and some vision preserved.